Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 TrialSimon C Crawford, Paul A Vasey, Jim Paul, et al.
BMC Bioinformatics|August 12, 2008
Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islandsWei Dai, Jens M Teodoridis, Janet Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survivalWei Dai, Jens M Teodoridis, Constanze Zeller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2013
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicitySarah McWhinney-Glass, Stacey J Winham, Daniel L Hertz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2010
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC seriesRoshan Agarwal, Charlie Gourley, Timothy J Perren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapySharon E Johnatty, Jonathan Beesley, Jim Paul, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|December 28, 2020
TMEM70 forms oligomeric scaffolds within mitochondrial cristae promoting in situ assembly of mammalian ATP synthase proton channelHela Bahri, Jeremie Buratto, Manuel Rojo, et al.
Pageof 3